Syndicate This week's upcoming IPO's and secondary offerings

Week of January 20 to January 24, 2024

This Day's Priced Deals: January 22nd, 2020

Symbol

Issuer

Type

Price

Managers

NNVC

NanoViricides
NanoViricides
Secondary
Priced: $3.00
2.5M
Aegis

Pricing after close

Managers: Aegis

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ADAP

Adaptimmune
Adaptimmune
Spot Secondary
Priced: $4.00
21M
TD Cowen

Pricing after close
Deal analysis and details

Managers: TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EFC

Ellington Financial
Ellington Financial
Spot Secondary
Priced: $18.29
4.6M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, Credit Suisse, BofA, UBS & Keefe Bruyette

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PROF

Profound Medical
Profound Medical
Spot Secondary
Priced: $11.65
2.95M
TD Cowen,...

Pricing after close
Deal analysis and details

Managers: TD Cowen, Raymond James

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
XENE

Xenon Pharmaceuticals
Xenon Pharmaceuticals
Spot Secondary
Priced: $16.00
3.75M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Stifel & Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

01/20 - Monday

Symbol

Issuer

Type

Price

Managers

IMGN

ImmunoGen
ImmunoGen
Spot Secondary
Priced: $4.25
21.325M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, TD Cowen & William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

01/21 - Tuesday

Symbol

Issuer

Type

Price

Managers

NNVC

NanoViricides
NanoViricides
Secondary
Priced: $3.00
2.5M
Aegis

Pricing after close

Managers: Aegis

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ADAP

Adaptimmune
Adaptimmune
Spot Secondary
Priced: $4.00
21M
TD Cowen

Pricing after close
Deal analysis and details

Managers: TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EFC

Ellington Financial
Ellington Financial
Spot Secondary
Priced: $18.29
4.6M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, Credit Suisse, BofA, UBS & Keefe Bruyette

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PROF

Profound Medical
Profound Medical
Spot Secondary
Priced: $11.65
2.95M
TD Cowen,...

Pricing after close
Deal analysis and details

Managers: TD Cowen, Raymond James

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
XENE

Xenon Pharmaceuticals
Xenon Pharmaceuticals
Spot Secondary
Priced: $16.00
3.75M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Stifel & Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

01/22 - Wednesday

Symbol

Issuer

Type

Price

Managers

KRTX

Karuna Therapeutics
Karuna Therapeutics
Block Trade
Priced: $99.75
2.1M
Goldman Sachs

Pricing after close

Managers: Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ELAN

Elanco
Elanco
Secondary
Priced: $32.00
23M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Citi & JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HCM

Hutchison China MediTech
Hutchison China MediTech
Secondary
Priced: $25.00
4.4M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Goldman Sachs & Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SIBN

SI-Bone
SI-Bone
Secondary
Priced: $21.50
4.3M
Morgan Stanley & BofA

Pricing after close

Managers: Morgan Stanley & BofA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ZLAB

Zai Lab
Zai Lab
Secondary
Priced: $47.50
6M
JPMorgan,...

Pricing after close

Managers: JPMorgan, Citi, Goldman Sachs, Leerink & Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ZYME

Zymeworks
Zymeworks
Secondary
Priced: $46.50
4.925M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Citi, Stifel & Wells Fargo, Raymond James

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ACRE

Ares Commercial
Ares Commercial
Spot Secondary
Priced: $16.09
4M
Wells Fargo,...

Pricing after close
Deal analysis and details

Managers: Wells Fargo, Citi & Morgan Stanley, JMP Securities, Raymond James

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AUTL

Autolus Therapeutics
Autolus Therapeutics
Spot Secondary
Priced: $11.00
7.25M
JPMorgan & Jefferies,...

Pricing after close
Deal analysis and details

Managers: JPMorgan & Jefferies, William Blair, H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BPMC

Blueprint Medicines
Blueprint Medicines
Spot Secondary
Priced: $69.00
4.71M
Goldman Sachs & TD Cowen,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs & TD Cowen, Canaccord, JMP Securities, Raymond James

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MSON

Misonix
Misonix
Spot Secondary
Priced: $18.50
1.625M
Canaccord,...

Pricing after close

Managers: Canaccord, BTIG, Craig-Hallum

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TRIL

Trillium Therapeutics
Trillium Therapeutics
Spot Secondary
Priced: $2.75
35.732M
TD Cowen

Pricing after close
Deal analysis and details

Managers: TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

01/23 - Thursday

Symbol

Issuer

Type

Price

Managers

ADPT

Adaptive Biotechnologies
Adaptive Biotechnologies
Secondary
Priced: $26.50
8M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Goldman Sachs, BofA, TD Cowen, Guggenheim & William Blair, BTIG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
APLT

Applied Therapeutics
Applied Therapeutics
Secondary
Priced: $45.50
2.74M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, TD Cowen & UBS

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IIPR

Innovative Industrial Properties
Innovative Industrial Properties
Spot Secondary
Priced: $73.25
2.97M
BTIG,...

Pricing after close
Deal analysis and details

Managers: BTIG, Compass Point, Ladenburg, Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access